Consistent with the hypothesis that platelet-derived mediators regulate AAA growth, mice administered daily (–) carvone showed suppressed AAA growth coincident with decreased MMP2 activity in the aorta (Figure 9C). The gene discussed is MMP2; the disease is triple-A syndrome.